BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20564074)

  • 81. Expression of MUC1 and MUC4 in gallbladder adenocarcinoma.
    Kim SM; Oh SJ; Hur B
    Korean J Pathol; 2012 Oct; 46(5):429-35. PubMed ID: 23136569
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The role and prognostic value of apoptosis in colorectal carcinoma.
    Alcaide J; Funez R; Rueda A; Perez-Ruiz E; Pereda T; Rodrigo I; Coveñas R; Muñoz M; Redondo M
    BMC Clin Pathol; 2013 Oct; 13(1):24. PubMed ID: 24106912
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Expression of Concern: Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.
    PLOS ONE Editors
    PLoS One; 2023; 18(4):e0285348. PubMed ID: 37115797
    [No Abstract]   [Full Text] [Related]  

  • 84. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
    Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
    J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Digital spatial profiling identifies molecular changes involved in development of colitis-associated colorectal cancer.
    Glyn T; Williams S; Whitehead M; Eglinton T; West N; Purcell RV
    Front Oncol; 2024; 14():1247106. PubMed ID: 38505585
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Relationship Between MUC4 Variants and Metastatic Recurrence in Colorectal Cancer.
    Liu J; Xing R; Shao J; Jiao S
    Int J Gen Med; 2023; 16():5077-5087. PubMed ID: 37942474
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels.
    Kwon MJ; Lee JY; Kim EJ; Ko EJ; Ryu CS; Cho HJ; Jun HH; Kim JW; Kim NK
    PLoS One; 2023; 18(6):e0287768. PubMed ID: 37384668
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Specific Targeting and Labeling of Colonic Polyps in
    Turner MA; Cox KE; Liu S; Neel N; Amirfakhri S; Nishino H; Hosseini M; Alcantara JA; Abd El-Hafeez AA; Lwin TM; Mallya K; Pisegna JR; Singh SK; Ghosh P; Hoffman RM; Batra SK; Bouvet M
    Curr Issues Mol Biol; 2023 Apr; 45(4):3347-3358. PubMed ID: 37185743
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.
    Muilenburg KM; Isder CC; Radhakrishnan P; Batra SK; Ly QP; Carlson MA; Bouvet M; Hollingsworth MA; Mohs AM
    Cancer Lett; 2023 May; 561():216150. PubMed ID: 36997106
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer.
    Cox KE; Liu S; Lwin TM; Hoffman RM; Batra SK; Bouvet M
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900282
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications.
    Turner MA; Hollandsworth HM; Amirfakhri S; Lwin TM; Nishino H; Neel NC; Natarajan G; Kaur S; Mallya K; Hoffman RM; Batra SK; Bouvet M
    Am J Surg; 2022 Oct; 224(4):1081-1085. PubMed ID: 35715267
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.
    Pothuraju R; Pai P; Chaudhary S; Siddiqui JA; Cox JL; Kaur S; Rachagani S; Roy HK; Bouvet M; Batra SK
    Aging (Albany NY); 2022 Mar; 14(5):2025-2046. PubMed ID: 35255004
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mucin in cancer: a stealth cloak for cancer cells.
    Wi DH; Cha JH; Jung YS
    BMB Rep; 2021 Jul; 54(7):344-355. PubMed ID: 34154702
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Roles of Transmembrane Mucins Located on Chromosome 7q22.1 in Colorectal Cancer.
    Almasmoum H
    Cancer Manag Res; 2021; 13():3271-3280. PubMed ID: 33883940
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation.
    Bresalier RS; Grady WM; Markowitz SD; Nielsen HJ; Batra SK; Lampe PD
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2431-2440. PubMed ID: 32299850
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer.
    Pothuraju R; Krishn SR; Gautam SK; Pai P; Ganguly K; Chaudhary S; Rachagani S; Kaur S; Batra SK
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32168759
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Correlation of Tn antigen expression with mucins in Chinese patients with colorectal cancer.
    Jiang Y; Liu Z; Hu Y; Gao T; Wen T; An G
    Int J Clin Exp Pathol; 2018; 11(3):1562-1568. PubMed ID: 31938254
    [No Abstract]   [Full Text] [Related]  

  • 98. Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Li C; Zuo D; Liu T; Yin L; Li C; Wang L
    Gastroenterol Res Pract; 2019; 2019():2391670. PubMed ID: 31933627
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.